Australia to review gene patents (full version)
Australia’s Senate launched an enquiry into the impact of granting gene patents in the country on November 19
The move comes after Australian company Genetic Technologies tried to enforce its exclusive licence to use patents owned by Myriad Genetics to test for the BRCA1 and BRCA2 genes. These genes increase the chances of breast cancer.
After widespread criticism...
Please log in
to read the rest of this article. New to Managing Intellectual Property?
Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.
Please make sure you log in to read the rest of the article.
Join us nowGain FREE access to up to five free articles when you register now.